Seoul's Seocho District will launch a national HPV vaccination support program for 12-year-old male adolescents (born in 2014) starting January 6. The move expands the previously female-focused support to include boys, aiming to strengthen prevention of infections and related diseases.
Human papillomavirus (HPV) can cause not only cervical cancer but also anal cancer, oropharyngeal cancer, and genital warts. Vaccination has been shown to provide high preventive efficacy in males as well. Eligible individuals can receive the HPV quadrivalent vaccine free of charge at designated medical institutions nationwide.
Seocho District plans to boost participation in the vaccination program through outreach in partnership with schools and the local community.
